nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—multiple sclerosis—Diazepam—epilepsy syndrome	0.0662	0.213	CpDpCtD
Dalfampridine—multiple sclerosis—Oxcarbazepine—epilepsy syndrome	0.0662	0.213	CpDpCtD
Dalfampridine—multiple sclerosis—Pregabalin—epilepsy syndrome	0.0563	0.181	CpDpCtD
Dalfampridine—KCNC4—epilepsy syndrome	0.0535	0.138	CbGaD
Dalfampridine—KCNB1—epilepsy syndrome	0.0535	0.138	CbGaD
Dalfampridine—KCNC1—epilepsy syndrome	0.0535	0.138	CbGaD
Dalfampridine—multiple sclerosis—Carbamazepine—epilepsy syndrome	0.0502	0.161	CpDpCtD
Dalfampridine—KCNQ4—epilepsy syndrome	0.0455	0.118	CbGaD
Dalfampridine—KCNV1—epilepsy syndrome	0.0406	0.105	CbGaD
Dalfampridine—multiple sclerosis—Clonazepam—epilepsy syndrome	0.0401	0.129	CpDpCtD
Dalfampridine—KCND2—epilepsy syndrome	0.0371	0.0958	CbGaD
Dalfampridine—KCNH1—epilepsy syndrome	0.0345	0.0891	CbGaD
Dalfampridine—KCNQ2—epilepsy syndrome	0.0345	0.0891	CbGaD
Dalfampridine—KCNQ3—epilepsy syndrome	0.0345	0.0891	CbGaD
Dalfampridine—multiple sclerosis—Gabapentin—epilepsy syndrome	0.0323	0.104	CpDpCtD
Dalfampridine—CYP2E1—Felbamate—epilepsy syndrome	0.0124	0.176	CbGbCtD
Dalfampridine—CYP2E1—Trimethadione—epilepsy syndrome	0.0124	0.176	CbGbCtD
Dalfampridine—CYP2E1—Clonazepam—epilepsy syndrome	0.0106	0.149	CbGbCtD
Dalfampridine—CYP2E1—Rufinamide—epilepsy syndrome	0.00863	0.122	CbGbCtD
Dalfampridine—CYP2E1—Propofol—epilepsy syndrome	0.00703	0.0993	CbGbCtD
Dalfampridine—CYP2E1—Phenobarbital—epilepsy syndrome	0.00672	0.0949	CbGbCtD
Dalfampridine—CYP2E1—Midazolam—epilepsy syndrome	0.00663	0.0935	CbGbCtD
Dalfampridine—CYP2E1—Diazepam—epilepsy syndrome	0.00637	0.0899	CbGbCtD
Dalfampridine—KCNA3—forebrain—epilepsy syndrome	0.000307	0.00592	CbGeAlD
Dalfampridine—KCNA4—forebrain—epilepsy syndrome	0.000307	0.00592	CbGeAlD
Dalfampridine—KCNA2—brainstem—epilepsy syndrome	0.000302	0.00583	CbGeAlD
Dalfampridine—KCNB1—telencephalon—epilepsy syndrome	0.000299	0.00576	CbGeAlD
Dalfampridine—KCNG2—cerebellum—epilepsy syndrome	0.000298	0.00576	CbGeAlD
Dalfampridine—KCNG4—head—epilepsy syndrome	0.000298	0.00575	CbGeAlD
Dalfampridine—KCNH4—head—epilepsy syndrome	0.000298	0.00575	CbGeAlD
Dalfampridine—KCNB2—head—epilepsy syndrome	0.000298	0.00575	CbGeAlD
Dalfampridine—KCNA2—forebrain—epilepsy syndrome	0.000292	0.00563	CbGeAlD
Dalfampridine—KCND1—brainstem—epilepsy syndrome	0.000289	0.00558	CbGeAlD
Dalfampridine—KCNA1—hindbrain—epilepsy syndrome	0.000289	0.00558	CbGeAlD
Dalfampridine—KCND3—hindbrain—epilepsy syndrome	0.000288	0.00555	CbGeAlD
Dalfampridine—KCNH4—nervous system—epilepsy syndrome	0.000283	0.00545	CbGeAlD
Dalfampridine—KCNB2—nervous system—epilepsy syndrome	0.000283	0.00545	CbGeAlD
Dalfampridine—KCNG4—nervous system—epilepsy syndrome	0.000283	0.00545	CbGeAlD
Dalfampridine—KCNA4—telencephalon—epilepsy syndrome	0.000282	0.00544	CbGeAlD
Dalfampridine—KCNA3—telencephalon—epilepsy syndrome	0.000282	0.00544	CbGeAlD
Dalfampridine—KCNC4—forebrain—epilepsy syndrome	0.000279	0.00539	CbGeAlD
Dalfampridine—KCNC1—brainstem—epilepsy syndrome	0.000278	0.00536	CbGeAlD
Dalfampridine—KCNH5—head—epilepsy syndrome	0.000273	0.00526	CbGeAlD
Dalfampridine—KCNH4—central nervous system—epilepsy syndrome	0.000272	0.00525	CbGeAlD
Dalfampridine—KCNB2—central nervous system—epilepsy syndrome	0.000272	0.00525	CbGeAlD
Dalfampridine—KCNG4—central nervous system—epilepsy syndrome	0.000272	0.00525	CbGeAlD
Dalfampridine—KCNA2—telencephalon—epilepsy syndrome	0.000268	0.00518	CbGeAlD
Dalfampridine—KCNS1—telencephalon—epilepsy syndrome	0.000268	0.00518	CbGeAlD
Dalfampridine—KCNC1—forebrain—epilepsy syndrome	0.000268	0.00517	CbGeAlD
Dalfampridine—KCNQ5—forebrain—epilepsy syndrome	0.000261	0.00503	CbGeAlD
Dalfampridine—KCNH5—nervous system—epilepsy syndrome	0.000258	0.00499	CbGeAlD
Dalfampridine—KCNC4—telencephalon—epilepsy syndrome	0.000257	0.00495	CbGeAlD
Dalfampridine—KCNA6—head—epilepsy syndrome	0.000253	0.00489	CbGeAlD
Dalfampridine—KCNS2—head—epilepsy syndrome	0.000253	0.00489	CbGeAlD
Dalfampridine—KCNH5—central nervous system—epilepsy syndrome	0.000249	0.0048	CbGeAlD
Dalfampridine—KCNC1—telencephalon—epilepsy syndrome	0.000247	0.00476	CbGeAlD
Dalfampridine—KCNH3—medulla oblongata—epilepsy syndrome	0.000242	0.00468	CbGeAlD
Dalfampridine—KCNG2—brain—epilepsy syndrome	0.000242	0.00468	CbGeAlD
Dalfampridine—KCNS2—nervous system—epilepsy syndrome	0.00024	0.00464	CbGeAlD
Dalfampridine—KCNA6—nervous system—epilepsy syndrome	0.00024	0.00464	CbGeAlD
Dalfampridine—KCNF1—forebrain—epilepsy syndrome	0.000239	0.00461	CbGeAlD
Dalfampridine—KCNV1—head—epilepsy syndrome	0.000238	0.0046	CbGeAlD
Dalfampridine—KCNH8—medulla oblongata—epilepsy syndrome	0.000235	0.00453	CbGeAlD
Dalfampridine—KCNS2—central nervous system—epilepsy syndrome	0.000231	0.00446	CbGeAlD
Dalfampridine—KCNA6—central nervous system—epilepsy syndrome	0.000231	0.00446	CbGeAlD
Dalfampridine—KCNV1—nervous system—epilepsy syndrome	0.000226	0.00436	CbGeAlD
Dalfampridine—KCNV2—head—epilepsy syndrome	0.000226	0.00436	CbGeAlD
Dalfampridine—KCNA4—medulla oblongata—epilepsy syndrome	0.000222	0.00428	CbGeAlD
Dalfampridine—KCNF1—telencephalon—epilepsy syndrome	0.00022	0.00424	CbGeAlD
Dalfampridine—KCNV1—central nervous system—epilepsy syndrome	0.000218	0.0042	CbGeAlD
Dalfampridine—KCNH3—spinal cord—epilepsy syndrome	0.000216	0.00417	CbGeAlD
Dalfampridine—KCNG4—brain—epilepsy syndrome	0.000216	0.00417	CbGeAlD
Dalfampridine—KCNH4—brain—epilepsy syndrome	0.000216	0.00417	CbGeAlD
Dalfampridine—KCNB2—brain—epilepsy syndrome	0.000216	0.00417	CbGeAlD
Dalfampridine—KCNG3—head—epilepsy syndrome	0.000216	0.00416	CbGeAlD
Dalfampridine—KCNC2—head—epilepsy syndrome	0.000216	0.00416	CbGeAlD
Dalfampridine—KCNH1—head—epilepsy syndrome	0.000216	0.00416	CbGeAlD
Dalfampridine—KCNH8—midbrain—epilepsy syndrome	0.000215	0.00414	CbGeAlD
Dalfampridine—KCNV2—nervous system—epilepsy syndrome	0.000214	0.00413	CbGeAlD
Dalfampridine—KCNA5—forebrain—epilepsy syndrome	0.000214	0.00413	CbGeAlD
Dalfampridine—KCNS1—medulla oblongata—epilepsy syndrome	0.000211	0.00407	CbGeAlD
Dalfampridine—KCNQ3—forebrain—epilepsy syndrome	0.000209	0.00404	CbGeAlD
Dalfampridine—KCNH8—spinal cord—epilepsy syndrome	0.000209	0.00404	CbGeAlD
Dalfampridine—KCNV2—central nervous system—epilepsy syndrome	0.000206	0.00398	CbGeAlD
Dalfampridine—KCNG3—nervous system—epilepsy syndrome	0.000204	0.00394	CbGeAlD
Dalfampridine—KCNC2—nervous system—epilepsy syndrome	0.000204	0.00394	CbGeAlD
Dalfampridine—KCNH1—nervous system—epilepsy syndrome	0.000204	0.00394	CbGeAlD
Dalfampridine—KCNA4—midbrain—epilepsy syndrome	0.000203	0.00391	CbGeAlD
Dalfampridine—KCNC4—medulla oblongata—epilepsy syndrome	0.000202	0.00389	CbGeAlD
Dalfampridine—KCNQ2—brainstem—epilepsy syndrome	0.0002	0.00385	CbGeAlD
Dalfampridine—KCNA3—spinal cord—epilepsy syndrome	0.000198	0.00381	CbGeAlD
Dalfampridine—KCNH5—brain—epilepsy syndrome	0.000198	0.00381	CbGeAlD
Dalfampridine—KCNH1—central nervous system—epilepsy syndrome	0.000197	0.0038	CbGeAlD
Dalfampridine—KCNC2—central nervous system—epilepsy syndrome	0.000197	0.0038	CbGeAlD
Dalfampridine—KCNG3—central nervous system—epilepsy syndrome	0.000197	0.0038	CbGeAlD
Dalfampridine—KCNA5—telencephalon—epilepsy syndrome	0.000197	0.00379	CbGeAlD
Dalfampridine—KCNC1—medulla oblongata—epilepsy syndrome	0.000194	0.00374	CbGeAlD
Dalfampridine—KCNS1—midbrain—epilepsy syndrome	0.000193	0.00372	CbGeAlD
Dalfampridine—KCNA2—midbrain—epilepsy syndrome	0.000193	0.00372	CbGeAlD
Dalfampridine—KCNQ2—forebrain—epilepsy syndrome	0.000193	0.00372	CbGeAlD
Dalfampridine—KCNQ3—telencephalon—epilepsy syndrome	0.000193	0.00371	CbGeAlD
Dalfampridine—KCNH1—cerebellum—epilepsy syndrome	0.000192	0.00371	CbGeAlD
Dalfampridine—KCNH3—head—epilepsy syndrome	0.000192	0.00371	CbGeAlD
Dalfampridine—KCNG1—head—epilepsy syndrome	0.000192	0.00371	CbGeAlD
Dalfampridine—KCNH6—forebrain—epilepsy syndrome	0.000191	0.00369	CbGeAlD
Dalfampridine—KCND2—brainstem—epilepsy syndrome	0.000189	0.00365	CbGeAlD
Dalfampridine—KCNA2—spinal cord—epilepsy syndrome	0.000188	0.00363	CbGeAlD
Dalfampridine—KCNB1—head—epilepsy syndrome	0.000186	0.00359	CbGeAlD
Dalfampridine—KCNH8—head—epilepsy syndrome	0.000186	0.00359	CbGeAlD
Dalfampridine—KCNC4—midbrain—epilepsy syndrome	0.000184	0.00356	CbGeAlD
Dalfampridine—KCNA6—brain—epilepsy syndrome	0.000184	0.00354	CbGeAlD
Dalfampridine—KCNS2—brain—epilepsy syndrome	0.000184	0.00354	CbGeAlD
Dalfampridine—KCND2—forebrain—epilepsy syndrome	0.000182	0.00352	CbGeAlD
Dalfampridine—KCNG1—nervous system—epilepsy syndrome	0.000182	0.00351	CbGeAlD
Dalfampridine—KCNH3—nervous system—epilepsy syndrome	0.000182	0.00351	CbGeAlD
Dalfampridine—KCNC3—head—epilepsy syndrome	0.000181	0.00348	CbGeAlD
Dalfampridine—KCNQ2—telencephalon—epilepsy syndrome	0.000177	0.00342	CbGeAlD
Dalfampridine—KCNC1—midbrain—epilepsy syndrome	0.000177	0.00342	CbGeAlD
Dalfampridine—KCNB1—nervous system—epilepsy syndrome	0.000176	0.0034	CbGeAlD
Dalfampridine—KCNH8—nervous system—epilepsy syndrome	0.000176	0.0034	CbGeAlD
Dalfampridine—KCNH6—telencephalon—epilepsy syndrome	0.000176	0.00339	CbGeAlD
Dalfampridine—KCNA3—head—epilepsy syndrome	0.000176	0.00339	CbGeAlD
Dalfampridine—KCNA4—head—epilepsy syndrome	0.000176	0.00339	CbGeAlD
Dalfampridine—KCNH3—central nervous system—epilepsy syndrome	0.000175	0.00338	CbGeAlD
Dalfampridine—KCNG1—central nervous system—epilepsy syndrome	0.000175	0.00338	CbGeAlD
Dalfampridine—KCNC1—spinal cord—epilepsy syndrome	0.000173	0.00333	CbGeAlD
Dalfampridine—KCNF1—medulla oblongata—epilepsy syndrome	0.000173	0.00333	CbGeAlD
Dalfampridine—KCNV1—brain—epilepsy syndrome	0.000173	0.00333	CbGeAlD
Dalfampridine—KCNQ5—midbrain—epilepsy syndrome	0.000172	0.00332	CbGeAlD
Dalfampridine—KCNH3—cerebellum—epilepsy syndrome	0.000171	0.00331	CbGeAlD
Dalfampridine—KCNG1—cerebellum—epilepsy syndrome	0.000171	0.00331	CbGeAlD
Dalfampridine—KCNC3—nervous system—epilepsy syndrome	0.000171	0.0033	CbGeAlD
Dalfampridine—KCNB1—central nervous system—epilepsy syndrome	0.00017	0.00328	CbGeAlD
Dalfampridine—KCNH8—central nervous system—epilepsy syndrome	0.00017	0.00328	CbGeAlD
Dalfampridine—KCND2—telencephalon—epilepsy syndrome	0.000168	0.00324	CbGeAlD
Dalfampridine—KCNS1—head—epilepsy syndrome	0.000167	0.00322	CbGeAlD
Dalfampridine—KCNA2—head—epilepsy syndrome	0.000167	0.00322	CbGeAlD
Dalfampridine—KCNA4—nervous system—epilepsy syndrome	0.000167	0.00321	CbGeAlD
Dalfampridine—KCNA3—nervous system—epilepsy syndrome	0.000167	0.00321	CbGeAlD
Dalfampridine—KCNH8—cerebellum—epilepsy syndrome	0.000166	0.0032	CbGeAlD
Dalfampridine—KCNA1—brainstem—epilepsy syndrome	0.000166	0.0032	CbGeAlD
Dalfampridine—KCNC3—central nervous system—epilepsy syndrome	0.000165	0.00318	CbGeAlD
Dalfampridine—KCND3—brainstem—epilepsy syndrome	0.000165	0.00318	CbGeAlD
Dalfampridine—KCNV2—brain—epilepsy syndrome	0.000164	0.00316	CbGeAlD
Dalfampridine—KCNC3—cerebellum—epilepsy syndrome	0.000161	0.00311	CbGeAlD
Dalfampridine—KCNA3—central nervous system—epilepsy syndrome	0.00016	0.00309	CbGeAlD
Dalfampridine—KCNA4—central nervous system—epilepsy syndrome	0.00016	0.00309	CbGeAlD
Dalfampridine—KCNA1—forebrain—epilepsy syndrome	0.00016	0.00309	CbGeAlD
Dalfampridine—KCNC4—head—epilepsy syndrome	0.00016	0.00308	CbGeAlD
Dalfampridine—KCND1—head—epilepsy syndrome	0.00016	0.00308	CbGeAlD
Dalfampridine—KCND3—forebrain—epilepsy syndrome	0.000159	0.00307	CbGeAlD
Dalfampridine—KCNS1—nervous system—epilepsy syndrome	0.000158	0.00306	CbGeAlD
Dalfampridine—KCNA2—nervous system—epilepsy syndrome	0.000158	0.00306	CbGeAlD
Dalfampridine—KCNF1—midbrain—epilepsy syndrome	0.000158	0.00305	CbGeAlD
Dalfampridine—KCNA4—cerebellum—epilepsy syndrome	0.000157	0.00302	CbGeAlD
Dalfampridine—KCNA3—cerebellum—epilepsy syndrome	0.000157	0.00302	CbGeAlD
Dalfampridine—KCNG3—brain—epilepsy syndrome	0.000156	0.00301	CbGeAlD
Dalfampridine—KCNC2—brain—epilepsy syndrome	0.000156	0.00301	CbGeAlD
Dalfampridine—KCNH1—brain—epilepsy syndrome	0.000156	0.00301	CbGeAlD
Dalfampridine—KCNA5—medulla oblongata—epilepsy syndrome	0.000154	0.00298	CbGeAlD
Dalfampridine—KCNF1—spinal cord—epilepsy syndrome	0.000154	0.00297	CbGeAlD
Dalfampridine—KCNH7—head—epilepsy syndrome	0.000154	0.00296	CbGeAlD
Dalfampridine—KCNC1—head—epilepsy syndrome	0.000154	0.00296	CbGeAlD
Dalfampridine—KCNQ4—head—epilepsy syndrome	0.000154	0.00296	CbGeAlD
Dalfampridine—KCNA2—central nervous system—epilepsy syndrome	0.000153	0.00294	CbGeAlD
Dalfampridine—KCNS1—central nervous system—epilepsy syndrome	0.000153	0.00294	CbGeAlD
Dalfampridine—KCNC4—nervous system—epilepsy syndrome	0.000152	0.00292	CbGeAlD
Dalfampridine—KCND1—nervous system—epilepsy syndrome	0.000152	0.00292	CbGeAlD
Dalfampridine—KCNS3—medulla oblongata—epilepsy syndrome	0.000151	0.00292	CbGeAlD
Dalfampridine—KCNQ3—medulla oblongata—epilepsy syndrome	0.000151	0.00292	CbGeAlD
Dalfampridine—KCNQ5—head—epilepsy syndrome	0.000149	0.00288	CbGeAlD
Dalfampridine—KCNA2—cerebellum—epilepsy syndrome	0.000149	0.00288	CbGeAlD
Dalfampridine—KCNA1—telencephalon—epilepsy syndrome	0.000147	0.00284	CbGeAlD
Dalfampridine—KCND3—telencephalon—epilepsy syndrome	0.000146	0.00282	CbGeAlD
Dalfampridine—KCNC4—central nervous system—epilepsy syndrome	0.000146	0.00281	CbGeAlD
Dalfampridine—KCND1—central nervous system—epilepsy syndrome	0.000146	0.00281	CbGeAlD
Dalfampridine—KCNH7—nervous system—epilepsy syndrome	0.000146	0.00281	CbGeAlD
Dalfampridine—KCNC1—nervous system—epilepsy syndrome	0.000146	0.00281	CbGeAlD
Dalfampridine—KCND1—cerebellum—epilepsy syndrome	0.000143	0.00275	CbGeAlD
Dalfampridine—KCNC4—cerebellum—epilepsy syndrome	0.000143	0.00275	CbGeAlD
Dalfampridine—KCNQ5—nervous system—epilepsy syndrome	0.000142	0.00273	CbGeAlD
Dalfampridine—KCNH7—central nervous system—epilepsy syndrome	0.00014	0.0027	CbGeAlD
Dalfampridine—KCNC1—central nervous system—epilepsy syndrome	0.00014	0.0027	CbGeAlD
Dalfampridine—KCNG1—brain—epilepsy syndrome	0.000139	0.00269	CbGeAlD
Dalfampridine—KCNH3—brain—epilepsy syndrome	0.000139	0.00269	CbGeAlD
Dalfampridine—KCNS3—midbrain—epilepsy syndrome	0.000138	0.00267	CbGeAlD
Dalfampridine—KCNQ3—midbrain—epilepsy syndrome	0.000138	0.00267	CbGeAlD
Dalfampridine—KCNA5—spinal cord—epilepsy syndrome	0.000138	0.00266	CbGeAlD
Dalfampridine—KCNH7—cerebellum—epilepsy syndrome	0.000137	0.00264	CbGeAlD
Dalfampridine—KCNC1—cerebellum—epilepsy syndrome	0.000137	0.00264	CbGeAlD
Dalfampridine—KCNQ4—cerebellum—epilepsy syndrome	0.000137	0.00264	CbGeAlD
Dalfampridine—KCNF1—head—epilepsy syndrome	0.000137	0.00264	CbGeAlD
Dalfampridine—KCNQ5—central nervous system—epilepsy syndrome	0.000136	0.00263	CbGeAlD
Dalfampridine—KCNS3—spinal cord—epilepsy syndrome	0.000135	0.0026	CbGeAlD
Dalfampridine—KCNB1—brain—epilepsy syndrome	0.000135	0.0026	CbGeAlD
Dalfampridine—KCNH8—brain—epilepsy syndrome	0.000135	0.0026	CbGeAlD
Dalfampridine—KCND2—medulla oblongata—epilepsy syndrome	0.000132	0.00254	CbGeAlD
Dalfampridine—KCNC3—brain—epilepsy syndrome	0.000131	0.00253	CbGeAlD
Dalfampridine—KCNF1—nervous system—epilepsy syndrome	0.00013	0.0025	CbGeAlD
Dalfampridine—KCNA4—brain—epilepsy syndrome	0.000127	0.00246	CbGeAlD
Dalfampridine—KCNA3—brain—epilepsy syndrome	0.000127	0.00246	CbGeAlD
Dalfampridine—KCNF1—central nervous system—epilepsy syndrome	0.000125	0.00241	CbGeAlD
Dalfampridine—KCNA5—head—epilepsy syndrome	0.000122	0.00236	CbGeAlD
Dalfampridine—KCNF1—cerebellum—epilepsy syndrome	0.000122	0.00236	CbGeAlD
Dalfampridine—KCNS1—brain—epilepsy syndrome	0.000121	0.00234	CbGeAlD
Dalfampridine—KCNA2—brain—epilepsy syndrome	0.000121	0.00234	CbGeAlD
Dalfampridine—KCND2—midbrain—epilepsy syndrome	0.00012	0.00232	CbGeAlD
Dalfampridine—KCNS3—head—epilepsy syndrome	0.00012	0.00231	CbGeAlD
Dalfampridine—KCNQ3—head—epilepsy syndrome	0.00012	0.00231	CbGeAlD
Dalfampridine—KCND2—spinal cord—epilepsy syndrome	0.000118	0.00227	CbGeAlD
Dalfampridine—KCNA5—nervous system—epilepsy syndrome	0.000116	0.00224	CbGeAlD
Dalfampridine—KCND1—brain—epilepsy syndrome	0.000116	0.00223	CbGeAlD
Dalfampridine—KCNC4—brain—epilepsy syndrome	0.000116	0.00223	CbGeAlD
Dalfampridine—KCNQ3—nervous system—epilepsy syndrome	0.000114	0.00219	CbGeAlD
Dalfampridine—KCNA5—central nervous system—epilepsy syndrome	0.000112	0.00216	CbGeAlD
Dalfampridine—KCNQ1—medulla oblongata—epilepsy syndrome	0.000111	0.00215	CbGeAlD
Dalfampridine—KCNH7—brain—epilepsy syndrome	0.000111	0.00215	CbGeAlD
Dalfampridine—KCNC1—brain—epilepsy syndrome	0.000111	0.00215	CbGeAlD
Dalfampridine—KCNQ4—brain—epilepsy syndrome	0.000111	0.00215	CbGeAlD
Dalfampridine—KCNQ2—head—epilepsy syndrome	0.00011	0.00213	CbGeAlD
Dalfampridine—KCNQ3—central nervous system—epilepsy syndrome	0.000109	0.00211	CbGeAlD
Dalfampridine—KCNH6—head—epilepsy syndrome	0.000109	0.00211	CbGeAlD
Dalfampridine—KCNQ5—brain—epilepsy syndrome	0.000108	0.00209	CbGeAlD
Dalfampridine—KCNQ3—cerebellum—epilepsy syndrome	0.000107	0.00206	CbGeAlD
Dalfampridine—KCNA1—midbrain—epilepsy syndrome	0.000106	0.00204	CbGeAlD
Dalfampridine—KCND3—midbrain—epilepsy syndrome	0.000105	0.00203	CbGeAlD
Dalfampridine—KCNQ2—nervous system—epilepsy syndrome	0.000105	0.00202	CbGeAlD
Dalfampridine—KCND2—head—epilepsy syndrome	0.000104	0.00202	CbGeAlD
Dalfampridine—KCNH6—nervous system—epilepsy syndrome	0.000104	0.002	CbGeAlD
Dalfampridine—KCNA1—spinal cord—epilepsy syndrome	0.000103	0.00199	CbGeAlD
Dalfampridine—KCNQ2—central nervous system—epilepsy syndrome	0.000101	0.00194	CbGeAlD
Dalfampridine—KCNH6—central nervous system—epilepsy syndrome	9.99e-05	0.00193	CbGeAlD
Dalfampridine—KCNF1—brain—epilepsy syndrome	9.92e-05	0.00191	CbGeAlD
Dalfampridine—KCND2—nervous system—epilepsy syndrome	9.91e-05	0.00191	CbGeAlD
Dalfampridine—KCNQ2—cerebellum—epilepsy syndrome	9.84e-05	0.0019	CbGeAlD
Dalfampridine—KCND2—central nervous system—epilepsy syndrome	9.54e-05	0.00184	CbGeAlD
Dalfampridine—KCND2—cerebellum—epilepsy syndrome	9.32e-05	0.0018	CbGeAlD
Dalfampridine—KCNA1—head—epilepsy syndrome	9.16e-05	0.00177	CbGeAlD
Dalfampridine—KCND3—head—epilepsy syndrome	9.11e-05	0.00176	CbGeAlD
Dalfampridine—KCNA5—brain—epilepsy syndrome	8.87e-05	0.00171	CbGeAlD
Dalfampridine—KCNQ1—head—epilepsy syndrome	8.82e-05	0.0017	CbGeAlD
Dalfampridine—KCNS3—brain—epilepsy syndrome	8.69e-05	0.00168	CbGeAlD
Dalfampridine—KCNQ3—brain—epilepsy syndrome	8.69e-05	0.00168	CbGeAlD
Dalfampridine—KCNA1—nervous system—epilepsy syndrome	8.68e-05	0.00167	CbGeAlD
Dalfampridine—KCND3—nervous system—epilepsy syndrome	8.64e-05	0.00167	CbGeAlD
Dalfampridine—KCNA1—central nervous system—epilepsy syndrome	8.36e-05	0.00161	CbGeAlD
Dalfampridine—KCND3—central nervous system—epilepsy syndrome	8.31e-05	0.0016	CbGeAlD
Dalfampridine—KCNA1—cerebellum—epilepsy syndrome	8.17e-05	0.00158	CbGeAlD
Dalfampridine—KCND3—cerebellum—epilepsy syndrome	8.13e-05	0.00157	CbGeAlD
Dalfampridine—KCNQ2—brain—epilepsy syndrome	8e-05	0.00154	CbGeAlD
Dalfampridine—KCNH6—brain—epilepsy syndrome	7.93e-05	0.00153	CbGeAlD
Dalfampridine—KCND2—brain—epilepsy syndrome	7.57e-05	0.00146	CbGeAlD
Dalfampridine—Asthenia—Levetiracetam—epilepsy syndrome	7.13e-05	0.00111	CcSEcCtD
Dalfampridine—Dyspnoea—Carbamazepine—epilepsy syndrome	7.11e-05	0.00111	CcSEcCtD
Dalfampridine—Constipation—Oxcarbazepine—epilepsy syndrome	7.1e-05	0.00111	CcSEcCtD
Dalfampridine—Urticaria—Felbamate—epilepsy syndrome	7.08e-05	0.0011	CcSEcCtD
Dalfampridine—Angiopathy—Pregabalin—epilepsy syndrome	7.07e-05	0.0011	CcSEcCtD
Dalfampridine—Vomiting—Acetazolamide—epilepsy syndrome	7.05e-05	0.0011	CcSEcCtD
Dalfampridine—Immune system disorder—Pregabalin—epilepsy syndrome	7.04e-05	0.0011	CcSEcCtD
Dalfampridine—Tremor—Valproic Acid—epilepsy syndrome	7.03e-05	0.0011	CcSEcCtD
Dalfampridine—Mediastinal disorder—Pregabalin—epilepsy syndrome	7.02e-05	0.00109	CcSEcCtD
Dalfampridine—Connective tissue disorder—Gabapentin—epilepsy syndrome	7.02e-05	0.00109	CcSEcCtD
Dalfampridine—Dyspepsia—Carbamazepine—epilepsy syndrome	7.02e-05	0.00109	CcSEcCtD
Dalfampridine—Insomnia—Lamotrigine—epilepsy syndrome	6.97e-05	0.00109	CcSEcCtD
Dalfampridine—Headache—Acetazolamide—epilepsy syndrome	6.94e-05	0.00108	CcSEcCtD
Dalfampridine—Urticaria—Zonisamide—epilepsy syndrome	6.93e-05	0.00108	CcSEcCtD
Dalfampridine—Feeling abnormal—Clonazepam—epilepsy syndrome	6.93e-05	0.00108	CcSEcCtD
Dalfampridine—Paraesthesia—Lamotrigine—epilepsy syndrome	6.92e-05	0.00108	CcSEcCtD
Dalfampridine—Hypersensitivity—Vigabatrin—epilepsy syndrome	6.89e-05	0.00107	CcSEcCtD
Dalfampridine—Asthenia—Fosphenytoin—epilepsy syndrome	6.89e-05	0.00107	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	6.88e-05	0.00107	CcSEcCtD
Dalfampridine—Feeling abnormal—Phenytoin—epilepsy syndrome	6.88e-05	0.00107	CcSEcCtD
Dalfampridine—Dyspnoea—Lamotrigine—epilepsy syndrome	6.87e-05	0.00107	CcSEcCtD
Dalfampridine—Angioedema—Valproic Acid—epilepsy syndrome	6.86e-05	0.00107	CcSEcCtD
Dalfampridine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	6.85e-05	0.00107	CcSEcCtD
Dalfampridine—Mental disorder—Pregabalin—epilepsy syndrome	6.83e-05	0.00106	CcSEcCtD
Dalfampridine—Constipation—Carbamazepine—epilepsy syndrome	6.82e-05	0.00106	CcSEcCtD
Dalfampridine—Dizziness—Propofol—epilepsy syndrome	6.81e-05	0.00106	CcSEcCtD
Dalfampridine—Hypersensitivity—Diazepam—epilepsy syndrome	6.79e-05	0.00106	CcSEcCtD
Dalfampridine—Dyspepsia—Lamotrigine—epilepsy syndrome	6.78e-05	0.00106	CcSEcCtD
Dalfampridine—Asthenia—Vigabatrin—epilepsy syndrome	6.71e-05	0.00105	CcSEcCtD
Dalfampridine—Infestation NOS—Topiramate—epilepsy syndrome	6.7e-05	0.00104	CcSEcCtD
Dalfampridine—Infestation—Topiramate—epilepsy syndrome	6.7e-05	0.00104	CcSEcCtD
Dalfampridine—Urticaria—Clonazepam—epilepsy syndrome	6.68e-05	0.00104	CcSEcCtD
Dalfampridine—Dizziness—Midazolam—epilepsy syndrome	6.66e-05	0.00104	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	6.65e-05	0.00104	CcSEcCtD
Dalfampridine—Urticaria—Phenytoin—epilepsy syndrome	6.64e-05	0.00103	CcSEcCtD
Dalfampridine—KCNA1—brain—epilepsy syndrome	6.64e-05	0.00128	CbGeAlD
Dalfampridine—Asthenia—Diazepam—epilepsy syndrome	6.61e-05	0.00103	CcSEcCtD
Dalfampridine—KCND3—brain—epilepsy syndrome	6.6e-05	0.00127	CbGeAlD
Dalfampridine—Urticaria—Oxcarbazepine—epilepsy syndrome	6.6e-05	0.00103	CcSEcCtD
Dalfampridine—Constipation—Lamotrigine—epilepsy syndrome	6.59e-05	0.00103	CcSEcCtD
Dalfampridine—Nausea—Acetazolamide—epilepsy syndrome	6.58e-05	0.00103	CcSEcCtD
Dalfampridine—Dizziness—Levetiracetam—epilepsy syndrome	6.58e-05	0.00102	CcSEcCtD
Dalfampridine—Feeling abnormal—Carbamazepine—epilepsy syndrome	6.57e-05	0.00102	CcSEcCtD
Dalfampridine—Back pain—Pregabalin—epilepsy syndrome	6.56e-05	0.00102	CcSEcCtD
Dalfampridine—Vomiting—Propofol—epilepsy syndrome	6.54e-05	0.00102	CcSEcCtD
Dalfampridine—Urinary tract infection—Topiramate—epilepsy syndrome	6.51e-05	0.00101	CcSEcCtD
Dalfampridine—Rash—Propofol—epilepsy syndrome	6.49e-05	0.00101	CcSEcCtD
Dalfampridine—Dermatitis—Propofol—epilepsy syndrome	6.48e-05	0.00101	CcSEcCtD
Dalfampridine—Immune system disorder—Gabapentin—epilepsy syndrome	6.45e-05	0.00101	CcSEcCtD
Dalfampridine—Headache—Propofol—epilepsy syndrome	6.45e-05	0.001	CcSEcCtD
Dalfampridine—Mediastinal disorder—Gabapentin—epilepsy syndrome	6.44e-05	0.001	CcSEcCtD
Dalfampridine—Hypersensitivity—Zonisamide—epilepsy syndrome	6.43e-05	0.001	CcSEcCtD
Dalfampridine—Vomiting—Midazolam—epilepsy syndrome	6.4e-05	0.000997	CcSEcCtD
Dalfampridine—Asthenia—Felbamate—epilepsy syndrome	6.4e-05	0.000996	CcSEcCtD
Dalfampridine—KCNQ1—brain—epilepsy syndrome	6.39e-05	0.00123	CbGeAlD
Dalfampridine—Chest pain—Valproic Acid—epilepsy syndrome	6.39e-05	0.000995	CcSEcCtD
Dalfampridine—Anxiety—Valproic Acid—epilepsy syndrome	6.37e-05	0.000992	CcSEcCtD
Dalfampridine—Tremor—Pregabalin—epilepsy syndrome	6.35e-05	0.00099	CcSEcCtD
Dalfampridine—Feeling abnormal—Lamotrigine—epilepsy syndrome	6.35e-05	0.000989	CcSEcCtD
Dalfampridine—Rash—Midazolam—epilepsy syndrome	6.35e-05	0.000989	CcSEcCtD
Dalfampridine—Dizziness—Fosphenytoin—epilepsy syndrome	6.35e-05	0.000989	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	6.34e-05	0.000988	CcSEcCtD
Dalfampridine—Dermatitis—Midazolam—epilepsy syndrome	6.34e-05	0.000988	CcSEcCtD
Dalfampridine—Urticaria—Carbamazepine—epilepsy syndrome	6.33e-05	0.000987	CcSEcCtD
Dalfampridine—Vomiting—Levetiracetam—epilepsy syndrome	6.32e-05	0.000985	CcSEcCtD
Dalfampridine—Headache—Midazolam—epilepsy syndrome	6.31e-05	0.000983	CcSEcCtD
Dalfampridine—Rash—Levetiracetam—epilepsy syndrome	6.27e-05	0.000977	CcSEcCtD
Dalfampridine—Dermatitis—Levetiracetam—epilepsy syndrome	6.26e-05	0.000976	CcSEcCtD
Dalfampridine—Asthenia—Zonisamide—epilepsy syndrome	6.26e-05	0.000975	CcSEcCtD
Dalfampridine—Mental disorder—Gabapentin—epilepsy syndrome	6.26e-05	0.000975	CcSEcCtD
Dalfampridine—Headache—Levetiracetam—epilepsy syndrome	6.23e-05	0.000971	CcSEcCtD
Dalfampridine—Angioedema—Pregabalin—epilepsy syndrome	6.2e-05	0.000966	CcSEcCtD
Dalfampridine—Hypersensitivity—Clonazepam—epilepsy syndrome	6.2e-05	0.000965	CcSEcCtD
Dalfampridine—Dizziness—Vigabatrin—epilepsy syndrome	6.19e-05	0.000964	CcSEcCtD
Dalfampridine—Confusional state—Valproic Acid—epilepsy syndrome	6.17e-05	0.000962	CcSEcCtD
Dalfampridine—Hypersensitivity—Phenytoin—epilepsy syndrome	6.15e-05	0.000959	CcSEcCtD
Dalfampridine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	6.12e-05	0.000954	CcSEcCtD
Dalfampridine—Urticaria—Lamotrigine—epilepsy syndrome	6.12e-05	0.000954	CcSEcCtD
Dalfampridine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.12e-05	0.000954	CcSEcCtD
Dalfampridine—Nausea—Propofol—epilepsy syndrome	6.11e-05	0.000952	CcSEcCtD
Dalfampridine—Vomiting—Fosphenytoin—epilepsy syndrome	6.1e-05	0.000951	CcSEcCtD
Dalfampridine—Dizziness—Diazepam—epilepsy syndrome	6.09e-05	0.000949	CcSEcCtD
Dalfampridine—Infection—Valproic Acid—epilepsy syndrome	6.08e-05	0.000948	CcSEcCtD
Dalfampridine—Rash—Fosphenytoin—epilepsy syndrome	6.05e-05	0.000943	CcSEcCtD
Dalfampridine—Dermatitis—Fosphenytoin—epilepsy syndrome	6.05e-05	0.000942	CcSEcCtD
Dalfampridine—Asthenia—Clonazepam—epilepsy syndrome	6.03e-05	0.00094	CcSEcCtD
Dalfampridine—Back pain—Gabapentin—epilepsy syndrome	6.02e-05	0.000937	CcSEcCtD
Dalfampridine—Headache—Fosphenytoin—epilepsy syndrome	6.01e-05	0.000937	CcSEcCtD
Dalfampridine—Nervous system disorder—Valproic Acid—epilepsy syndrome	6e-05	0.000936	CcSEcCtD
Dalfampridine—Asthenia—Phenytoin—epilepsy syndrome	5.99e-05	0.000934	CcSEcCtD
Dalfampridine—Nausea—Midazolam—epilepsy syndrome	5.98e-05	0.000932	CcSEcCtD
Dalfampridine—Asthenia—Oxcarbazepine—epilepsy syndrome	5.96e-05	0.000929	CcSEcCtD
Dalfampridine—Vomiting—Vigabatrin—epilepsy syndrome	5.95e-05	0.000927	CcSEcCtD
Dalfampridine—Skin disorder—Valproic Acid—epilepsy syndrome	5.95e-05	0.000927	CcSEcCtD
Dalfampridine—Connective tissue disorder—Topiramate—epilepsy syndrome	5.91e-05	0.00092	CcSEcCtD
Dalfampridine—Nausea—Levetiracetam—epilepsy syndrome	5.91e-05	0.00092	CcSEcCtD
Dalfampridine—Rash—Vigabatrin—epilepsy syndrome	5.9e-05	0.000919	CcSEcCtD
Dalfampridine—Dizziness—Felbamate—epilepsy syndrome	5.89e-05	0.000918	CcSEcCtD
Dalfampridine—Dermatitis—Vigabatrin—epilepsy syndrome	5.89e-05	0.000918	CcSEcCtD
Dalfampridine—Convulsion—Pregabalin—epilepsy syndrome	5.88e-05	0.000916	CcSEcCtD
Dalfampridine—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.87e-05	0.000915	CcSEcCtD
Dalfampridine—KCNH2—forebrain—epilepsy syndrome	5.87e-05	0.00113	CbGeAlD
Dalfampridine—Headache—Vigabatrin—epilepsy syndrome	5.86e-05	0.000913	CcSEcCtD
Dalfampridine—Vomiting—Diazepam—epilepsy syndrome	5.86e-05	0.000912	CcSEcCtD
Dalfampridine—Tremor—Gabapentin—epilepsy syndrome	5.83e-05	0.000908	CcSEcCtD
Dalfampridine—Rash—Diazepam—epilepsy syndrome	5.81e-05	0.000905	CcSEcCtD
Dalfampridine—Dermatitis—Diazepam—epilepsy syndrome	5.8e-05	0.000904	CcSEcCtD
Dalfampridine—Chest pain—Pregabalin—epilepsy syndrome	5.77e-05	0.0009	CcSEcCtD
Dalfampridine—Dizziness—Zonisamide—epilepsy syndrome	5.77e-05	0.000899	CcSEcCtD
Dalfampridine—Headache—Diazepam—epilepsy syndrome	5.77e-05	0.000899	CcSEcCtD
Dalfampridine—Anxiety—Pregabalin—epilepsy syndrome	5.75e-05	0.000897	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.73e-05	0.000893	CcSEcCtD
Dalfampridine—Hypotension—Valproic Acid—epilepsy syndrome	5.72e-05	0.000891	CcSEcCtD
Dalfampridine—Asthenia—Carbamazepine—epilepsy syndrome	5.72e-05	0.000891	CcSEcCtD
Dalfampridine—Nausea—Fosphenytoin—epilepsy syndrome	5.7e-05	0.000888	CcSEcCtD
Dalfampridine—Angioedema—Gabapentin—epilepsy syndrome	5.68e-05	0.000885	CcSEcCtD
Dalfampridine—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.68e-05	0.000885	CcSEcCtD
Dalfampridine—Vomiting—Felbamate—epilepsy syndrome	5.67e-05	0.000883	CcSEcCtD
Dalfampridine—Rash—Felbamate—epilepsy syndrome	5.62e-05	0.000876	CcSEcCtD
Dalfampridine—Dermatitis—Felbamate—epilepsy syndrome	5.61e-05	0.000875	CcSEcCtD
Dalfampridine—Headache—Felbamate—epilepsy syndrome	5.58e-05	0.00087	CcSEcCtD
Dalfampridine—Confusional state—Pregabalin—epilepsy syndrome	5.58e-05	0.00087	CcSEcCtD
Dalfampridine—Dizziness—Clonazepam—epilepsy syndrome	5.56e-05	0.000866	CcSEcCtD
Dalfampridine—Nausea—Vigabatrin—epilepsy syndrome	5.56e-05	0.000866	CcSEcCtD
Dalfampridine—Vomiting—Zonisamide—epilepsy syndrome	5.55e-05	0.000864	CcSEcCtD
Dalfampridine—Insomnia—Valproic Acid—epilepsy syndrome	5.54e-05	0.000863	CcSEcCtD
Dalfampridine—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.54e-05	0.000862	CcSEcCtD
Dalfampridine—Asthenia—Lamotrigine—epilepsy syndrome	5.53e-05	0.000861	CcSEcCtD
Dalfampridine—Dizziness—Phenytoin—epilepsy syndrome	5.52e-05	0.000861	CcSEcCtD
Dalfampridine—Rash—Zonisamide—epilepsy syndrome	5.5e-05	0.000857	CcSEcCtD
Dalfampridine—Infection—Pregabalin—epilepsy syndrome	5.5e-05	0.000857	CcSEcCtD
Dalfampridine—Paraesthesia—Valproic Acid—epilepsy syndrome	5.5e-05	0.000857	CcSEcCtD
Dalfampridine—Dermatitis—Zonisamide—epilepsy syndrome	5.5e-05	0.000856	CcSEcCtD
Dalfampridine—Dizziness—Oxcarbazepine—epilepsy syndrome	5.49e-05	0.000856	CcSEcCtD
Dalfampridine—Nausea—Diazepam—epilepsy syndrome	5.47e-05	0.000852	CcSEcCtD
Dalfampridine—Headache—Zonisamide—epilepsy syndrome	5.47e-05	0.000852	CcSEcCtD
Dalfampridine—Dyspnoea—Valproic Acid—epilepsy syndrome	5.46e-05	0.000851	CcSEcCtD
Dalfampridine—Angiopathy—Topiramate—epilepsy syndrome	5.45e-05	0.00085	CcSEcCtD
Dalfampridine—Immune system disorder—Topiramate—epilepsy syndrome	5.43e-05	0.000846	CcSEcCtD
Dalfampridine—Nervous system disorder—Pregabalin—epilepsy syndrome	5.43e-05	0.000846	CcSEcCtD
Dalfampridine—Mediastinal disorder—Topiramate—epilepsy syndrome	5.42e-05	0.000844	CcSEcCtD
Dalfampridine—KCNH2—telencephalon—epilepsy syndrome	5.4e-05	0.00104	CbGeAlD
Dalfampridine—Dyspepsia—Valproic Acid—epilepsy syndrome	5.39e-05	0.00084	CcSEcCtD
Dalfampridine—Convulsion—Gabapentin—epilepsy syndrome	5.39e-05	0.00084	CcSEcCtD
Dalfampridine—Skin disorder—Pregabalin—epilepsy syndrome	5.38e-05	0.000838	CcSEcCtD
Dalfampridine—Vomiting—Clonazepam—epilepsy syndrome	5.35e-05	0.000833	CcSEcCtD
Dalfampridine—Vomiting—Phenytoin—epilepsy syndrome	5.31e-05	0.000827	CcSEcCtD
Dalfampridine—Rash—Clonazepam—epilepsy syndrome	5.3e-05	0.000826	CcSEcCtD
Dalfampridine—Dermatitis—Clonazepam—epilepsy syndrome	5.3e-05	0.000825	CcSEcCtD
Dalfampridine—Chest pain—Gabapentin—epilepsy syndrome	5.29e-05	0.000825	CcSEcCtD
Dalfampridine—Nausea—Felbamate—epilepsy syndrome	5.29e-05	0.000825	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.29e-05	0.000824	CcSEcCtD
Dalfampridine—Vomiting—Oxcarbazepine—epilepsy syndrome	5.28e-05	0.000823	CcSEcCtD
Dalfampridine—Anxiety—Gabapentin—epilepsy syndrome	5.28e-05	0.000822	CcSEcCtD
Dalfampridine—Dizziness—Carbamazepine—epilepsy syndrome	5.27e-05	0.000821	CcSEcCtD
Dalfampridine—Headache—Clonazepam—epilepsy syndrome	5.27e-05	0.000821	CcSEcCtD
Dalfampridine—Rash—Phenytoin—epilepsy syndrome	5.27e-05	0.000821	CcSEcCtD
Dalfampridine—Mental disorder—Topiramate—epilepsy syndrome	5.27e-05	0.00082	CcSEcCtD
Dalfampridine—Dermatitis—Phenytoin—epilepsy syndrome	5.26e-05	0.00082	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.26e-05	0.000819	CcSEcCtD
Dalfampridine—Rash—Oxcarbazepine—epilepsy syndrome	5.24e-05	0.000816	CcSEcCtD
Dalfampridine—Constipation—Valproic Acid—epilepsy syndrome	5.24e-05	0.000816	CcSEcCtD
Dalfampridine—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.23e-05	0.000815	CcSEcCtD
Dalfampridine—Headache—Phenytoin—epilepsy syndrome	5.23e-05	0.000815	CcSEcCtD
Dalfampridine—Headache—Oxcarbazepine—epilepsy syndrome	5.2e-05	0.000811	CcSEcCtD
Dalfampridine—Nausea—Zonisamide—epilepsy syndrome	5.18e-05	0.000807	CcSEcCtD
Dalfampridine—Hypotension—Pregabalin—epilepsy syndrome	5.17e-05	0.000806	CcSEcCtD
Dalfampridine—Confusional state—Gabapentin—epilepsy syndrome	5.12e-05	0.000797	CcSEcCtD
Dalfampridine—Dizziness—Lamotrigine—epilepsy syndrome	5.1e-05	0.000794	CcSEcCtD
Dalfampridine—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.08e-05	0.000791	CcSEcCtD
Dalfampridine—Vomiting—Carbamazepine—epilepsy syndrome	5.07e-05	0.00079	CcSEcCtD
Dalfampridine—Back pain—Topiramate—epilepsy syndrome	5.06e-05	0.000789	CcSEcCtD
Dalfampridine—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.05e-05	0.000786	CcSEcCtD
Dalfampridine—Infection—Gabapentin—epilepsy syndrome	5.04e-05	0.000786	CcSEcCtD
Dalfampridine—Rash—Carbamazepine—epilepsy syndrome	5.03e-05	0.000783	CcSEcCtD
Dalfampridine—Dermatitis—Carbamazepine—epilepsy syndrome	5.02e-05	0.000783	CcSEcCtD
Dalfampridine—Insomnia—Pregabalin—epilepsy syndrome	5.01e-05	0.00078	CcSEcCtD
Dalfampridine—Nausea—Clonazepam—epilepsy syndrome	4.99e-05	0.000778	CcSEcCtD
Dalfampridine—Headache—Carbamazepine—epilepsy syndrome	4.99e-05	0.000778	CcSEcCtD
Dalfampridine—Nervous system disorder—Gabapentin—epilepsy syndrome	4.98e-05	0.000776	CcSEcCtD
Dalfampridine—Paraesthesia—Pregabalin—epilepsy syndrome	4.97e-05	0.000774	CcSEcCtD
Dalfampridine—Nausea—Phenytoin—epilepsy syndrome	4.96e-05	0.000773	CcSEcCtD
Dalfampridine—Dyspnoea—Pregabalin—epilepsy syndrome	4.94e-05	0.000769	CcSEcCtD
Dalfampridine—Nausea—Oxcarbazepine—epilepsy syndrome	4.94e-05	0.000769	CcSEcCtD
Dalfampridine—Skin disorder—Gabapentin—epilepsy syndrome	4.93e-05	0.000768	CcSEcCtD
Dalfampridine—Tremor—Topiramate—epilepsy syndrome	4.9e-05	0.000764	CcSEcCtD
Dalfampridine—Vomiting—Lamotrigine—epilepsy syndrome	4.9e-05	0.000763	CcSEcCtD
Dalfampridine—Urticaria—Valproic Acid—epilepsy syndrome	4.86e-05	0.000758	CcSEcCtD
Dalfampridine—Rash—Lamotrigine—epilepsy syndrome	4.86e-05	0.000757	CcSEcCtD
Dalfampridine—Dermatitis—Lamotrigine—epilepsy syndrome	4.85e-05	0.000756	CcSEcCtD
Dalfampridine—Headache—Lamotrigine—epilepsy syndrome	4.83e-05	0.000752	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.78e-05	0.000745	CcSEcCtD
Dalfampridine—Hypotension—Gabapentin—epilepsy syndrome	4.74e-05	0.000739	CcSEcCtD
Dalfampridine—Nausea—Carbamazepine—epilepsy syndrome	4.74e-05	0.000738	CcSEcCtD
Dalfampridine—Constipation—Pregabalin—epilepsy syndrome	4.73e-05	0.000738	CcSEcCtD
Dalfampridine—Insomnia—Gabapentin—epilepsy syndrome	4.59e-05	0.000715	CcSEcCtD
Dalfampridine—Nausea—Lamotrigine—epilepsy syndrome	4.58e-05	0.000713	CcSEcCtD
Dalfampridine—Feeling abnormal—Pregabalin—epilepsy syndrome	4.56e-05	0.000711	CcSEcCtD
Dalfampridine—Paraesthesia—Gabapentin—epilepsy syndrome	4.56e-05	0.00071	CcSEcCtD
Dalfampridine—Convulsion—Topiramate—epilepsy syndrome	4.53e-05	0.000706	CcSEcCtD
Dalfampridine—Dyspnoea—Gabapentin—epilepsy syndrome	4.53e-05	0.000705	CcSEcCtD
Dalfampridine—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.51e-05	0.000703	CcSEcCtD
Dalfampridine—Dyspepsia—Gabapentin—epilepsy syndrome	4.47e-05	0.000696	CcSEcCtD
Dalfampridine—Chest pain—Topiramate—epilepsy syndrome	4.45e-05	0.000694	CcSEcCtD
Dalfampridine—Anxiety—Topiramate—epilepsy syndrome	4.44e-05	0.000692	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.42e-05	0.000689	CcSEcCtD
Dalfampridine—Urticaria—Pregabalin—epilepsy syndrome	4.4e-05	0.000685	CcSEcCtD
Dalfampridine—Asthenia—Valproic Acid—epilepsy syndrome	4.39e-05	0.000684	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.38e-05	0.000683	CcSEcCtD
Dalfampridine—Constipation—Gabapentin—epilepsy syndrome	4.34e-05	0.000676	CcSEcCtD
Dalfampridine—Confusional state—Topiramate—epilepsy syndrome	4.31e-05	0.000671	CcSEcCtD
Dalfampridine—KCNH2—medulla oblongata—epilepsy syndrome	4.24e-05	0.000819	CbGeAlD
Dalfampridine—Infection—Topiramate—epilepsy syndrome	4.24e-05	0.000661	CcSEcCtD
Dalfampridine—Nervous system disorder—Topiramate—epilepsy syndrome	4.19e-05	0.000653	CcSEcCtD
Dalfampridine—Feeling abnormal—Gabapentin—epilepsy syndrome	4.18e-05	0.000652	CcSEcCtD
Dalfampridine—CYP2E1—telencephalon—epilepsy syndrome	4.16e-05	0.000802	CbGeAlD
Dalfampridine—Skin disorder—Topiramate—epilepsy syndrome	4.15e-05	0.000646	CcSEcCtD
Dalfampridine—Hypersensitivity—Pregabalin—epilepsy syndrome	4.08e-05	0.000635	CcSEcCtD
Dalfampridine—Dizziness—Valproic Acid—epilepsy syndrome	4.05e-05	0.000631	CcSEcCtD
Dalfampridine—Urticaria—Gabapentin—epilepsy syndrome	4.03e-05	0.000628	CcSEcCtD
Dalfampridine—Hypotension—Topiramate—epilepsy syndrome	3.99e-05	0.000622	CcSEcCtD
Dalfampridine—Asthenia—Pregabalin—epilepsy syndrome	3.97e-05	0.000619	CcSEcCtD
Dalfampridine—Vomiting—Valproic Acid—epilepsy syndrome	3.89e-05	0.000607	CcSEcCtD
Dalfampridine—KCNH2—midbrain—epilepsy syndrome	3.88e-05	0.000748	CbGeAlD
Dalfampridine—Insomnia—Topiramate—epilepsy syndrome	3.86e-05	0.000602	CcSEcCtD
Dalfampridine—Rash—Valproic Acid—epilepsy syndrome	3.86e-05	0.000602	CcSEcCtD
Dalfampridine—Dermatitis—Valproic Acid—epilepsy syndrome	3.86e-05	0.000601	CcSEcCtD
Dalfampridine—Headache—Valproic Acid—epilepsy syndrome	3.84e-05	0.000598	CcSEcCtD
Dalfampridine—Paraesthesia—Topiramate—epilepsy syndrome	3.83e-05	0.000597	CcSEcCtD
Dalfampridine—Dyspnoea—Topiramate—epilepsy syndrome	3.81e-05	0.000593	CcSEcCtD
Dalfampridine—KCNH2—spinal cord—epilepsy syndrome	3.78e-05	0.00073	CbGeAlD
Dalfampridine—Dyspepsia—Topiramate—epilepsy syndrome	3.76e-05	0.000586	CcSEcCtD
Dalfampridine—Hypersensitivity—Gabapentin—epilepsy syndrome	3.74e-05	0.000583	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.69e-05	0.000574	CcSEcCtD
Dalfampridine—Dizziness—Pregabalin—epilepsy syndrome	3.66e-05	0.00057	CcSEcCtD
Dalfampridine—Constipation—Topiramate—epilepsy syndrome	3.65e-05	0.000569	CcSEcCtD
Dalfampridine—Asthenia—Gabapentin—epilepsy syndrome	3.64e-05	0.000567	CcSEcCtD
Dalfampridine—Nausea—Valproic Acid—epilepsy syndrome	3.64e-05	0.000567	CcSEcCtD
Dalfampridine—Vomiting—Pregabalin—epilepsy syndrome	3.52e-05	0.000548	CcSEcCtD
Dalfampridine—Feeling abnormal—Topiramate—epilepsy syndrome	3.52e-05	0.000548	CcSEcCtD
Dalfampridine—Rash—Pregabalin—epilepsy syndrome	3.49e-05	0.000544	CcSEcCtD
Dalfampridine—Dermatitis—Pregabalin—epilepsy syndrome	3.49e-05	0.000543	CcSEcCtD
Dalfampridine—Headache—Pregabalin—epilepsy syndrome	3.47e-05	0.00054	CcSEcCtD
Dalfampridine—Urticaria—Topiramate—epilepsy syndrome	3.39e-05	0.000529	CcSEcCtD
Dalfampridine—KCNH2—head—epilepsy syndrome	3.36e-05	0.000649	CbGeAlD
Dalfampridine—Dizziness—Gabapentin—epilepsy syndrome	3.36e-05	0.000523	CcSEcCtD
Dalfampridine—Nausea—Pregabalin—epilepsy syndrome	3.29e-05	0.000512	CcSEcCtD
Dalfampridine—CYP2E1—medulla oblongata—epilepsy syndrome	3.27e-05	0.00063	CbGeAlD
Dalfampridine—Vomiting—Gabapentin—epilepsy syndrome	3.23e-05	0.000503	CcSEcCtD
Dalfampridine—Rash—Gabapentin—epilepsy syndrome	3.2e-05	0.000499	CcSEcCtD
Dalfampridine—Dermatitis—Gabapentin—epilepsy syndrome	3.2e-05	0.000498	CcSEcCtD
Dalfampridine—KCNH2—nervous system—epilepsy syndrome	3.19e-05	0.000615	CbGeAlD
Dalfampridine—Headache—Gabapentin—epilepsy syndrome	3.18e-05	0.000495	CcSEcCtD
Dalfampridine—Hypersensitivity—Topiramate—epilepsy syndrome	3.15e-05	0.00049	CcSEcCtD
Dalfampridine—KCNH2—central nervous system—epilepsy syndrome	3.07e-05	0.000592	CbGeAlD
Dalfampridine—Asthenia—Topiramate—epilepsy syndrome	3.06e-05	0.000477	CcSEcCtD
Dalfampridine—Nausea—Gabapentin—epilepsy syndrome	3.02e-05	0.00047	CcSEcCtD
Dalfampridine—KCNH2—cerebellum—epilepsy syndrome	3e-05	0.000579	CbGeAlD
Dalfampridine—CYP2E1—spinal cord—epilepsy syndrome	2.91e-05	0.000562	CbGeAlD
Dalfampridine—Dizziness—Topiramate—epilepsy syndrome	2.82e-05	0.00044	CcSEcCtD
Dalfampridine—Vomiting—Topiramate—epilepsy syndrome	2.72e-05	0.000423	CcSEcCtD
Dalfampridine—Rash—Topiramate—epilepsy syndrome	2.69e-05	0.00042	CcSEcCtD
Dalfampridine—Dermatitis—Topiramate—epilepsy syndrome	2.69e-05	0.000419	CcSEcCtD
Dalfampridine—Headache—Topiramate—epilepsy syndrome	2.68e-05	0.000417	CcSEcCtD
Dalfampridine—CYP2E1—head—epilepsy syndrome	2.59e-05	0.0005	CbGeAlD
Dalfampridine—Nausea—Topiramate—epilepsy syndrome	2.54e-05	0.000395	CcSEcCtD
Dalfampridine—CYP2E1—nervous system—epilepsy syndrome	2.46e-05	0.000474	CbGeAlD
Dalfampridine—KCNH2—brain—epilepsy syndrome	2.44e-05	0.00047	CbGeAlD
Dalfampridine—CYP2E1—central nervous system—epilepsy syndrome	2.36e-05	0.000456	CbGeAlD
Dalfampridine—CYP2E1—cerebellum—epilepsy syndrome	2.31e-05	0.000446	CbGeAlD
Dalfampridine—CYP2E1—brain—epilepsy syndrome	1.88e-05	0.000362	CbGeAlD
Dalfampridine—KCNC2—Metabolism—GLUL—epilepsy syndrome	2.75e-06	2.41e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—CDC42—epilepsy syndrome	2.74e-06	2.39e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—CDC42—epilepsy syndrome	2.74e-06	2.39e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ST3GAL3—epilepsy syndrome	2.72e-06	2.38e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—GAD1—epilepsy syndrome	2.71e-06	2.37e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CACNA1D—epilepsy syndrome	2.7e-06	2.36e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CACNA1D—epilepsy syndrome	2.7e-06	2.36e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CACNA1D—epilepsy syndrome	2.7e-06	2.36e-05	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	2.67e-06	2.33e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ADSL—epilepsy syndrome	2.66e-06	2.33e-05	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—AKT1—epilepsy syndrome	2.62e-06	2.29e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GLUL—epilepsy syndrome	2.61e-06	2.28e-05	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—PRKCB—epilepsy syndrome	2.6e-06	2.27e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—GABBR1—epilepsy syndrome	2.59e-06	2.26e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CACNA1D—epilepsy syndrome	2.56e-06	2.24e-05	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—PRKCB—epilepsy syndrome	2.56e-06	2.24e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	2.53e-06	2.21e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TXNRD1—epilepsy syndrome	2.53e-06	2.21e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TXNRD1—epilepsy syndrome	2.53e-06	2.21e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TXNRD1—epilepsy syndrome	2.53e-06	2.21e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—GRIA1—epilepsy syndrome	2.52e-06	2.21e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—SLC6A1—epilepsy syndrome	2.52e-06	2.21e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—GRIN2A—epilepsy syndrome	2.52e-06	2.21e-05	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—JUN—epilepsy syndrome	2.5e-06	2.18e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AQP1—epilepsy syndrome	2.46e-06	2.15e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AQP1—epilepsy syndrome	2.46e-06	2.15e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AQP1—epilepsy syndrome	2.46e-06	2.15e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—FYN—epilepsy syndrome	2.44e-06	2.13e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—FYN—epilepsy syndrome	2.44e-06	2.13e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TXNRD1—epilepsy syndrome	2.4e-06	2.1e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—CHRNB2—epilepsy syndrome	2.39e-06	2.09e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—DLG4—epilepsy syndrome	2.37e-06	2.07e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—DLG4—epilepsy syndrome	2.37e-06	2.07e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	2.37e-06	2.07e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	2.33e-06	2.04e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AQP1—epilepsy syndrome	2.33e-06	2.04e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—GRIN2B—epilepsy syndrome	2.32e-06	2.03e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—GRIN2B—epilepsy syndrome	2.32e-06	2.03e-05	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	2.29e-06	2e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	2.24e-06	1.96e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—KCNJ11—epilepsy syndrome	2.22e-06	1.94e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—KCNJ11—epilepsy syndrome	2.22e-06	1.94e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CHRM3—epilepsy syndrome	2.22e-06	1.94e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—KCNJ11—epilepsy syndrome	2.22e-06	1.94e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CHRM3—epilepsy syndrome	2.22e-06	1.94e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CHRM3—epilepsy syndrome	2.22e-06	1.94e-05	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—JUN—epilepsy syndrome	2.18e-06	1.91e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—PRKCB—epilepsy syndrome	2.18e-06	1.9e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—PRKCB—epilepsy syndrome	2.18e-06	1.9e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—CHRNA4—epilepsy syndrome	2.17e-06	1.9e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	2.16e-06	1.89e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT3—epilepsy syndrome	2.14e-06	1.87e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT3—epilepsy syndrome	2.14e-06	1.87e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CHRM3—epilepsy syndrome	2.11e-06	1.84e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—KCNJ11—epilepsy syndrome	2.11e-06	1.84e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	2.09e-06	1.83e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ADAM10—epilepsy syndrome	2.09e-06	1.83e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ADAM10—epilepsy syndrome	2.09e-06	1.83e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	2.07e-06	1.81e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	2.06e-06	1.8e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KDR—epilepsy syndrome	2.01e-06	1.76e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KDR—epilepsy syndrome	2.01e-06	1.76e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	1.97e-06	1.72e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CDC42—epilepsy syndrome	1.95e-06	1.71e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CDC42—epilepsy syndrome	1.95e-06	1.71e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6ST—epilepsy syndrome	1.92e-06	1.68e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6ST—epilepsy syndrome	1.92e-06	1.68e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BCHE—epilepsy syndrome	1.91e-06	1.67e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—DLG4—epilepsy syndrome	1.87e-06	1.63e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—GRIN2B—epilepsy syndrome	1.82e-06	1.59e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCG2—epilepsy syndrome	1.81e-06	1.58e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCG2—epilepsy syndrome	1.81e-06	1.58e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCG2—epilepsy syndrome	1.81e-06	1.58e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—PLCB1—epilepsy syndrome	1.8e-06	1.58e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HES1—epilepsy syndrome	1.79e-06	1.56e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HES1—epilepsy syndrome	1.79e-06	1.56e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2C19—epilepsy syndrome	1.76e-06	1.54e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP2C19—epilepsy syndrome	1.76e-06	1.54e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2C19—epilepsy syndrome	1.76e-06	1.54e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP11A1—epilepsy syndrome	1.75e-06	1.53e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP11A1—epilepsy syndrome	1.75e-06	1.53e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP11A1—epilepsy syndrome	1.75e-06	1.53e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FYN—epilepsy syndrome	1.74e-06	1.52e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FYN—epilepsy syndrome	1.74e-06	1.52e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MEF2C—epilepsy syndrome	1.73e-06	1.51e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MEF2C—epilepsy syndrome	1.73e-06	1.51e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCG2—epilepsy syndrome	1.72e-06	1.5e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2C19—epilepsy syndrome	1.67e-06	1.46e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP11A1—epilepsy syndrome	1.66e-06	1.45e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2D6—epilepsy syndrome	1.58e-06	1.38e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP2D6—epilepsy syndrome	1.58e-06	1.38e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2D6—epilepsy syndrome	1.58e-06	1.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.53e-06	1.34e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ADRA2A—epilepsy syndrome	1.51e-06	1.32e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ADRA2A—epilepsy syndrome	1.51e-06	1.32e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ADRA2A—epilepsy syndrome	1.51e-06	1.32e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2D6—epilepsy syndrome	1.5e-06	1.31e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—BCHE—epilepsy syndrome	1.5e-06	1.31e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—BCHE—epilepsy syndrome	1.5e-06	1.31e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—BCHE—epilepsy syndrome	1.5e-06	1.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP2C19—epilepsy syndrome	1.5e-06	1.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP11A1—epilepsy syndrome	1.49e-06	1.3e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.48e-06	1.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.47e-06	1.28e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KDR—epilepsy syndrome	1.43e-06	1.25e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KDR—epilepsy syndrome	1.43e-06	1.25e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC2A1—epilepsy syndrome	1.43e-06	1.25e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC2A1—epilepsy syndrome	1.43e-06	1.25e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC2A1—epilepsy syndrome	1.43e-06	1.25e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ADRA2A—epilepsy syndrome	1.43e-06	1.25e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—BCHE—epilepsy syndrome	1.42e-06	1.24e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PLCB1—epilepsy syndrome	1.42e-06	1.24e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PLCB1—epilepsy syndrome	1.42e-06	1.24e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PLCB1—epilepsy syndrome	1.42e-06	1.24e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TH—epilepsy syndrome	1.41e-06	1.23e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TH—epilepsy syndrome	1.41e-06	1.23e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TH—epilepsy syndrome	1.41e-06	1.23e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6ST—epilepsy syndrome	1.37e-06	1.2e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6ST—epilepsy syndrome	1.37e-06	1.2e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC2A1—epilepsy syndrome	1.36e-06	1.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP2D6—epilepsy syndrome	1.34e-06	1.18e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PLCB1—epilepsy syndrome	1.34e-06	1.17e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TH—epilepsy syndrome	1.34e-06	1.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.33e-06	1.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.24e-06	1.08e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—epilepsy syndrome	1.23e-06	1.08e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—epilepsy syndrome	1.23e-06	1.08e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMOX1—epilepsy syndrome	1.18e-06	1.03e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—epilepsy syndrome	1.18e-06	1.03e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—epilepsy syndrome	1.18e-06	1.03e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	1.17e-06	1.02e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	1.16e-06	1.02e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAT—epilepsy syndrome	1.16e-06	1.02e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAT—epilepsy syndrome	1.16e-06	1.02e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAT—epilepsy syndrome	1.16e-06	1.02e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—SRC—epilepsy syndrome	1.14e-06	9.93e-06	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—SRC—epilepsy syndrome	1.14e-06	9.93e-06	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	1.13e-06	9.89e-06	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—epilepsy syndrome	1.13e-06	9.88e-06	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCB1—epilepsy syndrome	1.13e-06	9.88e-06	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—epilepsy syndrome	1.13e-06	9.88e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—epilepsy syndrome	1.12e-06	9.76e-06	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FGF2—epilepsy syndrome	1.11e-06	9.71e-06	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FGF2—epilepsy syndrome	1.11e-06	9.71e-06	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—epilepsy syndrome	1.11e-06	9.67e-06	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—epilepsy syndrome	1.11e-06	9.67e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAT—epilepsy syndrome	1.1e-06	9.63e-06	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—PRKCB—epilepsy syndrome	1.08e-06	9.48e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—epilepsy syndrome	1.07e-06	9.37e-06	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GPX1—epilepsy syndrome	1.05e-06	9.19e-06	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GPX1—epilepsy syndrome	1.05e-06	9.19e-06	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GPX1—epilepsy syndrome	1.05e-06	9.19e-06	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RELA—epilepsy syndrome	1.03e-06	9.02e-06	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RELA—epilepsy syndrome	1.03e-06	9.02e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA13—epilepsy syndrome	1.03e-06	8.97e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GPX1—epilepsy syndrome	9.96e-07	8.71e-06	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	9.88e-07	8.64e-06	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AGT—epilepsy syndrome	9.21e-07	8.05e-06	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AGT—epilepsy syndrome	9.21e-07	8.05e-06	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AGT—epilepsy syndrome	9.21e-07	8.05e-06	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOE—epilepsy syndrome	9.02e-07	7.89e-06	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOE—epilepsy syndrome	9.02e-07	7.89e-06	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOE—epilepsy syndrome	9.02e-07	7.89e-06	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—epilepsy syndrome	8.79e-07	7.69e-06	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—epilepsy syndrome	8.79e-07	7.69e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AGT—epilepsy syndrome	8.73e-07	7.64e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOE—epilepsy syndrome	8.55e-07	7.48e-06	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	8.47e-07	7.41e-06	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SRC—epilepsy syndrome	8.1e-07	7.09e-06	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SRC—epilepsy syndrome	8.1e-07	7.09e-06	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—epilepsy syndrome	7.89e-07	6.9e-06	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—epilepsy syndrome	7.89e-07	6.9e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—L2HGDH—epilepsy syndrome	7.77e-07	6.8e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CERS1—epilepsy syndrome	7.77e-07	6.8e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FAR1—epilepsy syndrome	7.77e-07	6.8e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADK—epilepsy syndrome	7.77e-07	6.8e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GLUD1—epilepsy syndrome	7.77e-07	6.8e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PDXK—epilepsy syndrome	7.77e-07	6.8e-06	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—POMC—epilepsy syndrome	7.75e-07	6.78e-06	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—POMC—epilepsy syndrome	7.75e-07	6.78e-06	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—POMC—epilepsy syndrome	7.75e-07	6.78e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—POMC—epilepsy syndrome	7.35e-07	6.43e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NHLRC1—epilepsy syndrome	7.11e-07	6.21e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—EPM2A—epilepsy syndrome	7.11e-07	6.21e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GAMT—epilepsy syndrome	7.11e-07	6.21e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PNPO—epilepsy syndrome	7.11e-07	6.21e-06	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—epilepsy syndrome	7.07e-07	6.18e-06	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—epilepsy syndrome	7.07e-07	6.18e-06	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—epilepsy syndrome	7.07e-07	6.18e-06	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—epilepsy syndrome	6.76e-07	5.91e-06	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—epilepsy syndrome	6.76e-07	5.91e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—epilepsy syndrome	6.7e-07	5.86e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—QDPR—epilepsy syndrome	6.61e-07	5.78e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA4—epilepsy syndrome	6.61e-07	5.78e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—POMC—epilepsy syndrome	6.59e-07	5.76e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COX3—epilepsy syndrome	6.21e-07	5.43e-06	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—epilepsy syndrome	6.18e-07	5.41e-06	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—epilepsy syndrome	6.18e-07	5.41e-06	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—epilepsy syndrome	6.18e-07	5.41e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PFKL—epilepsy syndrome	5.89e-07	5.15e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLCO1A2—epilepsy syndrome	5.89e-07	5.15e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CACNA2D2—epilepsy syndrome	5.89e-07	5.15e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—KCNB1—epilepsy syndrome	5.89e-07	5.15e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC6A8—epilepsy syndrome	5.89e-07	5.15e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—epilepsy syndrome	5.86e-07	5.13e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ATIC—epilepsy syndrome	5.39e-07	4.71e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UPB1—epilepsy syndrome	5.39e-07	4.71e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NEU1—epilepsy syndrome	5.39e-07	4.71e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD17B4—epilepsy syndrome	5.18e-07	4.53e-06	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—epilepsy syndrome	5.03e-07	4.4e-06	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—epilepsy syndrome	5.03e-07	4.4e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GBE1—epilepsy syndrome	5.01e-07	4.38e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPP1R3C—epilepsy syndrome	5.01e-07	4.38e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ASAH1—epilepsy syndrome	4.71e-07	4.12e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STXBP1—epilepsy syndrome	4.58e-07	4e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NT5E—epilepsy syndrome	4.46e-07	3.9e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALAD—epilepsy syndrome	4.46e-07	3.9e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDH7A1—epilepsy syndrome	4.26e-07	3.72e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CACNA1A—epilepsy syndrome	4.26e-07	3.72e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ST3GAL3—epilepsy syndrome	4.17e-07	3.64e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADSL—epilepsy syndrome	4.08e-07	3.57e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GLUL—epilepsy syndrome	4e-07	3.5e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CACNA1D—epilepsy syndrome	3.93e-07	3.44e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TXNRD1—epilepsy syndrome	3.67e-07	3.21e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AQP1—epilepsy syndrome	3.57e-07	3.12e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—KCNJ11—epilepsy syndrome	3.23e-07	2.82e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CHRM3—epilepsy syndrome	3.23e-07	2.82e-06	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—epilepsy syndrome	3.11e-07	2.72e-06	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—epilepsy syndrome	3.11e-07	2.72e-06	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—epilepsy syndrome	3.11e-07	2.72e-06	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—epilepsy syndrome	2.95e-07	2.58e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	2.63e-07	2.3e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	2.56e-07	2.24e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	2.55e-07	2.23e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	2.3e-07	2.01e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	2.19e-07	1.91e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BCHE—epilepsy syndrome	2.18e-07	1.91e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	2.08e-07	1.82e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	2.06e-07	1.8e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TH—epilepsy syndrome	2.05e-07	1.79e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.71e-07	1.5e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.69e-07	1.48e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.64e-07	1.44e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.53e-07	1.33e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.34e-07	1.17e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.31e-07	1.15e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.13e-07	9.85e-07	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.03e-07	8.98e-07	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	8.98e-08	7.86e-07	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	4.52e-08	3.95e-07	CbGpPWpGaD
